Ammonium tetrathiomolybdate is used to treat Wilson’s disease by chelating excess copper in the body. It is also studied for its potential in treating cancer and neurodegenerative disorders due to its copper-lowering effect. In industry, it serves as a molybdenum source in catalysts and lubricants. Additionally, it is used in biochemical research involving molybdenum-containing enzymes. The directory classifies it as a clinical API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Tiomolibdate diammonium, ATTM, ammonium thiomolybdate and Ammonium molybdenum sulfide. It is also listed for alternate use as: API Intermediate. Its PubChem CID is 15251598.
Ammonium tetrathiomolybdate
| CAS No | 15060-55-6 |
|---|---|
| Molecular Formula | H10MoN2S4 |
| Molecular Weight | 262.3 g/mol |
| Synonyms | diazanium;bis(sulfanylidene)molybdenum;sulfanide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ammonium tetrathiomolybdate is used to treat Wilson’s disease by chelating excess copper in the body. It is also studied for its potential in treating cancer and neurodegenerative disorders due to its copper-lowering effect.
The listed CAS number is 15060-55-6.
The listed molecular formula is H10MoN2S4.
The listed molecular weight is 262.3 g/mol.
diazanium;bis(sulfanylidene)molybdenum;sulfanide.
The source lists Tiomolibdate diammonium, ATTM, ammonium thiomolybdate and Ammonium molybdenum sulfide.